Intriguingly, IDH1 and IDH2 mutations were also found in other myeloid disorders such as myeloproliferative neoplasms (MPN) and myelodysplastic syndrome (MDS) which have a propensity to AML development, although at a much lower frequency than AML [42,43]. This evidence concerns the gene IDH2 and acute myeloid leukemia.